Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 128 (4) , 518-523
- https://doi.org/10.1016/s0022-3476(96)70363-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trialThe Journal of Pediatrics, 1995
- Pharmacokinetics of Epoetin (Recombinant Human Erythropoietin) after Long Term Therapy in Patients Undergoing Haemodialysis and HaemofiltrationClinical Pharmacokinetics, 1993
- Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: A multicenter studyThe Journal of Pediatrics, 1993
- Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failureThe Journal of Pediatrics, 1992
- Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infantsThe Journal of Pediatrics, 1992
- Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemiaThe Journal of Pediatrics, 1992
- Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot studyThe Journal of Pediatrics, 1991
- Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot studyThe Journal of Pediatrics, 1990
- Circulating pluripotent hematopoietic progenitor cells in neonatesThe Journal of Pediatrics, 1987
- Pharmacologic studies in neonates given large dosages of ampicillinThe Journal of Pediatrics, 1974